Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Chronic Heart Failure

  Free Subscription

Articles published in Clin Cardiol

Retrieve available abstracts of 86 articles:
HTML format

Single Articles

    August 2022
  1. AHLGRIM C, Seiler F, Birkner P, Schoechlin S, et al
    Clinically unrecognized plasma volume expansion predicts long-term all-cause-mortality in chronic heart failure.
    Clin Cardiol. 2022 Aug 3. doi: 10.1002/clc.23893.
    PubMed     Abstract available

  2. SHANG W, Zhang Y, Han D
    Benefits of tolvaptan on early dyspnea relief in patients with acute heart failure: A meta-analysis.
    Clin Cardiol. 2022 Aug 2. doi: 10.1002/clc.23889.
    PubMed     Abstract available

    July 2022
  3. LIU YX, Chen W, Lin X, Zhu YL, et al
    Initiating ivabradine during hospitalization in patients with acute heart failure: A real-world experience in China.
    Clin Cardiol. 2022 Jul 23. doi: 10.1002/clc.23880.
    PubMed     Abstract available

  4. FREEDMAN BL, Berg DD, Scirica BM, Bohula EA, et al
    Epidemiology of heart failure hospitalization in patients with stable atherothrombotic disease: Insights from the TRA 2 degrees P-TIMI 50 trial.
    Clin Cardiol. 2022 Jul 19. doi: 10.1002/clc.23843.
    PubMed     Abstract available

  5. VICTORIA-CASTRO AM, Martin M, Yamamoto Y, Ahmad T, et al
    Pragmatic randomized trial assessing the impact of digital health technology on quality of life in patients with heart failure: Design, rationale and implementation.
    Clin Cardiol. 2022 Jul 12. doi: 10.1002/clc.23848.
    PubMed     Abstract available

    June 2022
  6. LIAO LP, Yang Y, Wu Y, Li W, et al
    Correlation analysis of the triglyceride glucose index and heart failure with preserved ejection fraction in essential hypertensive patients.
    Clin Cardiol. 2022 Jun 29. doi: 10.1002/clc.23881.
    PubMed     Abstract available

  7. NAKAGAWA Y, Imamura T
    Detailed association between the etiologies of heart failure and occurrence of sleep-disordered breathing.
    Clin Cardiol. 2022 Jun 22. doi: 10.1002/clc.23875.

  8. SCIRICA BM, Im K, Murphy SA, Kuder JF, et al
    Re-adjudication of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) with study-level meta-analysis of hospitalization for heart failure from cardiovascular outcomes trials with dipeptidyl peptidase-4 (DPP-4) inhibitors.
    Clin Cardiol. 2022 Jun 17. doi: 10.1002/clc.23844.
    PubMed     Abstract available

  9. DEVORE AD, Bosworth HB, Granger BB
    Improving implementation of evidence-based therapies for heart failure.
    Clin Cardiol. 2022;45 Suppl 1:S52-S59.
    PubMed     Abstract available

  10. TALHA KM, Butler J
    Breakthroughs in the treatment of heart failure with mildly reduced and preserved ejection fraction.
    Clin Cardiol. 2022;45 Suppl 1:S31-S39.
    PubMed     Abstract available

  11. MCMURRAY JJV, Docherty KF
    Insights into foundational therapies for heart failure with reduced ejection fraction.
    Clin Cardiol. 2022;45 Suppl 1:S26-S30.
    PubMed     Abstract available

  12. CHANDRAMOULI C, Stewart S, Almahmeed W, Lam CSP, et al
    Clinical implications of the universal definition for the prevention and treatment of heart failure.
    Clin Cardiol. 2022;45 Suppl 1:S2-S12.
    PubMed     Abstract available

    Advances in the management of heart failure.
    Clin Cardiol. 2022;45 Suppl 1:S1.

  14. OSTROMINSKI JW, Vaduganathan M
    Evolving therapeutic strategies for patients hospitalized with new or worsening heart failure across the spectrum of left ventricular ejection fraction.
    Clin Cardiol. 2022;45 Suppl 1:S40-S51.
    PubMed     Abstract available

  15. HAMMOND MM, Everitt IK, Khan SS
    New strategies and therapies for the prevention of heart failure in high-risk patients.
    Clin Cardiol. 2022;45 Suppl 1:S13-S25.
    PubMed     Abstract available

    May 2022
  16. LIANG L, Huang L, Zhao X, Zhao L, et al
    Prognostic value of RDW alone and in combination with NT-proBNP in patients with heart failure.
    Clin Cardiol. 2022 May 27. doi: 10.1002/clc.23850.
    PubMed     Abstract available

  17. GU G, Wu J, Gao X, Liu M, et al
    Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction: A meta-analysis.
    Clin Cardiol. 2022 May 11. doi: 10.1002/clc.23841.
    PubMed     Abstract available

  18. WANG T, Yu FC, Wei Q, Xu X, et al
    Sleep-disordered breathing in heart failure patients with different etiologies.
    Clin Cardiol. 2022 May 10. doi: 10.1002/clc.23840.
    PubMed     Abstract available

  19. GUERRA F, D'Onofrio A, De Ruvo E, Manzo M, et al
    Decongestive treatment adjustments in heart failure patients remotely monitored with a multiparametric implantable defibrillators algorithm.
    Clin Cardiol. 2022 May 3. doi: 10.1002/clc.23832.
    PubMed     Abstract available

    April 2022
  20. ROTH ME, Chinn ME, Dunn SP, Bilchick KC, et al
    Association of colchicine use for acute gout with clinical outcomes in acute decompensated heart failure.
    Clin Cardiol. 2022 Apr 28. doi: 10.1002/clc.23830.
    PubMed     Abstract available

    March 2022
  21. DEL CID FRATTI J, Salazar M, Argueta-Sosa EE
    Vaccine-preventable disease hospitalized patients with heart failure with reduced ejection fraction.
    Clin Cardiol. 2022 Mar 10. doi: 10.1002/clc.23800.
    PubMed     Abstract available

  22. LAUFER-PERL M, Sadon S, Zahler D, Milwidsky A, et al
    Repetitive milrinone therapy in ambulatory advanced heart failure patients.
    Clin Cardiol. 2022 Mar 4. doi: 10.1002/clc.23802.
    PubMed     Abstract available

  23. WEN XS, Luo R, Liu J, Liu ZQ, et al
    The duration of beta-blocker therapy and outcomes in patients without heart failure or left ventricular systolic dysfunction after acute myocardial infarction: A multicenter prospective cohort study.
    Clin Cardiol. 2022 Mar 4. doi: 10.1002/clc.23807.
    PubMed     Abstract available

  24. LEAHOVA-CERCHEZ X, Berthelot E, Genet B, Hanon O, et al
    Estimation of the plasma volume status of elderly patients with acute decompensated heart failure using bedside clinical, biological, and ultrasound parameters.
    Clin Cardiol. 2022 Mar 2. doi: 10.1002/clc.23791.
    PubMed     Abstract available

    February 2022
  25. KRITTAYAPHONG R, Pumprueg S, Sairat P
    Soluble ST2 in the prediction of heart failure and death in patients with atrial fibrillation.
    Clin Cardiol. 2022 Feb 21. doi: 10.1002/clc.23799.
    PubMed     Abstract available

  26. HOSEINI SG, Heshmat-Ghahdarijani K, Khosrawi S, Garakyaraghi M, et al
    Melatonin supplementation improves N-terminal pro-B-type natriuretic peptide levels and quality of life in patients with heart failure with reduced ejection fraction: Results from MeHR trial, a randomized clinical trial.
    Clin Cardiol. 2022 Feb 16. doi: 10.1002/clc.23796.
    PubMed     Abstract available

  27. HWANG JW, Kim DG, Kim H, Kwak JJ, et al
    Impact of chronic kidney disease on clinical outcomes in patients with Stage B progressive aortic regurgitation (mild to moderate and moderate grades).
    Clin Cardiol. 2022 Feb 16. doi: 10.1002/clc.23792.
    PubMed     Abstract available

  28. AMBROSY AP, Malik UI, Leong TK, Allen AR, et al
    Food security, diet quality, nutritional knowledge, and attitudes towards research in adults with heart failure during the COVID-19 pandemic.
    Clin Cardiol. 2022 Feb 2. doi: 10.1002/clc.23761.
    PubMed     Abstract available

    January 2022
  29. PARK J, Zhong X, Babaie Sarijaloo F, Wokhlu A, et al
    Tailored risk assessment of 90-day acute heart failure readmission or all-cause death to heart failure with preserved versus reduced ejection fraction.
    Clin Cardiol. 2022 Jan 25. doi: 10.1002/clc.23780.
    PubMed     Abstract available

  30. COOPER LB, Bruce S, Psotka M, Mentz R, et al
    Proteomic differences among patients with heart failure taking furosemide or torsemide.
    Clin Cardiol. 2022 Jan 11. doi: 10.1002/clc.23733.
    PubMed     Abstract available

  31. LIANG M, Bian B, Yang Q
    Characteristics and long-term prognosis of patients with reduced, mid-range, and preserved ejection fraction: A systemic review and meta-analysis.
    Clin Cardiol. 2022;45:5-17.
    PubMed     Abstract available

    December 2021
  32. KONIG S, Pellissier V, Leiner J, Hohenstein S, et al
    Expected and observed in-hospital mortality in heart failure patients before and during the COVID-19 pandemic: Introduction of the machine learning-based standardized mortality ratio at Helios hospitals.
    Clin Cardiol. 2021 Dec 23. doi: 10.1002/clc.23762.
    PubMed     Abstract available

  33. KAPTEIN YE, Kaptein EM
    Comparison of subclavian vein to inferior vena cava collapsibility by ultrasound in acute heart failure: A pilot study.
    Clin Cardiol. 2021 Dec 21. doi: 10.1002/clc.23758.
    PubMed     Abstract available

    October 2021
  34. EMMENS JE, Ter Maaten JM, Brouwers FP, Kieneker LM, et al
    Proenkephalin and the risk of new-onset heart failure: data from prevention of renal and vascular end-stage disease.
    Clin Cardiol. 2021 Oct 30. doi: 10.1002/clc.23729.
    PubMed     Abstract available

  35. DIAO K, Wang D, Chen Z, Wu X, et al
    Rationale and design of a multi-center, prospective randomized controlled trial on the effects of sacubitril-valsartan versus enalapril on left ventricular remodeling in ST-elevation myocardial infarction: The PERI-STEMI study.
    Clin Cardiol. 2021 Oct 20. doi: 10.1002/clc.23744.
    PubMed     Abstract available

  36. LI N, Zhu Y, Zeng J
    Clinical value of pulmonary congestion detection by lung ultrasound in patients with chronic heart failure.
    Clin Cardiol. 2021 Oct 1. doi: 10.1002/clc.23738.
    PubMed     Abstract available

    September 2021
  37. PACHECO C, Wei J, Shufelt C, C Hitzeman T, et al
    Association of coronary microvascular dysfunction and cardiac bridge integrator 1, a cardiomyocyte dysfunction biomarker.
    Clin Cardiol. 2021 Sep 16. doi: 10.1002/clc.23726.
    PubMed     Abstract available

  38. BEL HAJ ALI K, Sekma A, Nouira S
    Response to "practical implication of nitroglycerin test for diagnosing heart failure in emergency department".
    Clin Cardiol. 2021 Sep 13. doi: 10.1002/clc.23721.

    August 2021
  39. ZHAO J, Zeng Y, Shen X
    Efficacy and safety of early initiation of Sacubitril/Valsartan in patients after acute myocardial infarction: A meta-analysis.
    Clin Cardiol. 2021 Aug 31. doi: 10.1002/clc.23717.
    PubMed     Abstract available

  40. HIROI S, Izumida T, Imamura T
    Practical implication of nitroglycerin test for diagnosing heart failure in emergency department.
    Clin Cardiol. 2021 Aug 29. doi: 10.1002/clc.23722.

  41. MCCULLOUGH PA, Mehta HS, Barker CM, Van Houten J, et al
    Mortality and guideline-directed medical therapy in real-world heart failure patients with reduced ejection fraction.
    Clin Cardiol. 2021 Aug 3. doi: 10.1002/clc.23664.
    PubMed     Abstract available

  42. SU Y, Hua W, Shen F, Zou J, et al
    Left ventricular-only fusion pacing versus cardiac resynchronization therapy in heart failure patients: A randomized controlled trial.
    Clin Cardiol. 2021 Aug 3. doi: 10.1002/clc.23616.
    PubMed     Abstract available

    July 2021
  43. OSHIMA A, Imamura T, Narang N, Kinugawa K, et al
    Management of hyperkalemia in chronic heart failure using sodium zirconium cyclosilicate.
    Clin Cardiol. 2021 Jul 15. doi: 10.1002/clc.23683.
    PubMed     Abstract available

  44. ZHANG D, Lai W, Liu X, Shen Y, et al
    The safety of morphine in patients with acute heart failure: A systematic review and meta-analysis.
    Clin Cardiol. 2021 Jul 8. doi: 10.1002/clc.23691.
    PubMed     Abstract available

    June 2021
  45. HOSEINI SG, Heshmat-Ghahdarijani K, Khosrawi S, Garakyaraghi M, et al
    Effect of melatonin supplementation on endothelial function in heart failure with reduced ejection fraction: A randomized, double-blinded clinical trial.
    Clin Cardiol. 2021 Jun 28. doi: 10.1002/clc.23682.
    PubMed     Abstract available

  46. BEAUVAIS F, Tartiere L, Pezel T, Motet C, et al
    First symptoms and health care pathways in hospitalized patients with acute heart failure: ICPS2 survey. A report from the Heart Failure Working Group (GICC) of the French Society of Cardiology.
    Clin Cardiol. 2021 Jun 26. doi: 10.1002/clc.23666.
    PubMed     Abstract available

  47. VAN WOERDEN G, van Veldhuisen DJ, Gorter TM, van Empel VPM, et al
    Importance of epicardial adipose tissue localization using cardiac magnetic resonance imaging in patients with heart failure with mid-range and preserved ejection fraction.
    Clin Cardiol. 2021 Jun 4. doi: 10.1002/clc.23644.
    PubMed     Abstract available

  48. SEKMA A, Bel Haj Ali K, Jeddi C, Ben Brahim N, et al
    Value of nitroglycerin test in the diagnosis of heart failure in emergency department patients with undifferentiated dyspnea.
    Clin Cardiol. 2021 Jun 2. doi: 10.1002/clc.23615.
    PubMed     Abstract available

    May 2021
  49. TAKABAYASHI K, Kitaguchi S, Yamamoto T, Takenaka K, et al
    Mode of death in elderly and super-elderly patients with acute heart failure: Insights from Japanese heart failure registry.
    Clin Cardiol. 2021 May 8. doi: 10.1002/clc.23619.
    PubMed     Abstract available

  50. KOBAYASHI M, Voors AA, Ouwerkerk W, Duarte K, et al
    Perceived risk profile and treatment optimization in heart failure: an analysis from BIOlogy Study to TAilored Treatment in chronic heart failure.
    Clin Cardiol. 2021 May 7. doi: 10.1002/clc.23576.
    PubMed     Abstract available

    March 2021
  51. WANG SJ, Cheng ZX, Fan XT, Lian YG, et al
    Development of an optimized risk score to predict short-term death among acute myocardial infarction patients in rural China.
    Clin Cardiol. 2021 Mar 25. doi: 10.1002/clc.23598.
    PubMed     Abstract available

  52. NARANG N, Dela Cruz M, Imamura T, Chung B, et al
    Discordance between lactic acidemia and hemodynamics in patients with advanced heart failure.
    Clin Cardiol. 2021 Mar 18. doi: 10.1002/clc.23584.
    PubMed     Abstract available

  53. LAM CSP, Wood R, Vaduganathan M, Bueno H, et al
    Contemporary economic burden in a real-world heart failure population with Commercial and Medicare supplemental plans.
    Clin Cardiol. 2021 Mar 11. doi: 10.1002/clc.23585.
    PubMed     Abstract available

    February 2021
  54. BRYAN RICHARD S, Huang B, Liu G, Yang Y, et al
    Impact of ivabradine on the cardiac function of chronic heart failure reduced ejection fraction: Meta-analysis of randomized controlled trials.
    Clin Cardiol. 2021 Feb 27. doi: 10.1002/clc.23581.
    PubMed     Abstract available

  55. YAZAKI M, Nabeta T, Ako J
    Response to letter to the editor entitled "Association between left atrial sphericity index and clinical outcomes in patients with systolic heart failure".
    Clin Cardiol. 2021 Feb 8. doi: 10.1002/clc.23563.

  56. CHAPMAN M, Imamura T
    Association between left atrial sphericity index and clinical outcomes in patients with systolic heart failure.
    Clin Cardiol. 2021 Feb 4. doi: 10.1002/clc.23562.

    January 2021
  57. CHEN J, Yu P, Ma J, Zheng C, et al
    Does subclinical atrial fibrillation independently predict adverse outcomes in patients with heart failure and cardiac resynchronization therapy defibrillator.
    Clin Cardiol. 2021 Jan 19. doi: 10.1002/clc.23547.

  58. PANDEY AC, Jer D, Kuo RS, Yoo DH, et al
    Novel doses of sacubitril/valsartan in patients unable to tolerate traditional therapy: Effects on N-terminal pro B-type natriuretic peptide levels.
    Clin Cardiol. 2021;44:85-90.
    PubMed     Abstract available

    December 2020
  59. LEE CJ, Ryu HY, Chun KH, Oh J, et al
    Association of muscular fitness with rehospitalization for heart failure with reduced ejection fraction.
    Clin Cardiol. 2020 Dec 25. doi: 10.1002/clc.23535.
    PubMed     Abstract available

  60. SARIJALOO F, Park J, Zhong X, Wokhlu A, et al
    Predicting 90 day acute heart failure readmission and death using machine learning-supported decision analysis.
    Clin Cardiol. 2020 Dec 23. doi: 10.1002/clc.23532.
    PubMed     Abstract available

    November 2020
  61. JOHANSEN ME, Argyropoulos C
    The cardiovascular outcomes, heart failure and kidney disease trials tell that the time to use Sodium Glucose Cotransporter 2 inhibitors is now.
    Clin Cardiol. 2020 Nov 9. doi: 10.1002/clc.23508.
    PubMed     Abstract available

  62. MUK B, Vamos M, Bogyi P, Szabo B, et al
    The impact of serum concentration-guided digoxin therapy on mortality of heart failure patients: A long-term follow-up, propensity-matched cohort study.
    Clin Cardiol. 2020 Nov 3. doi: 10.1002/clc.23500.
    PubMed     Abstract available

    October 2020
  63. SHENG CC, Sahoo D, Dugar S, Prada RA, et al
    Canakinumab to reduce deterioration of cardiac and respiratory function in SARS-CoV-2 associated myocardial injury with heightened inflammation (canakinumab in Covid-19 cardiac injury: The three C study).
    Clin Cardiol. 2020;43:1055-1063.
    PubMed     Abstract available

    September 2020
  64. ARAI S, Kawamura M, Gokan T, Yoshikawa K, et al
    Relationship between device-detected subclinical atrial fibrillation and heart failure in patients with cardiac resynchronization therapy defibrillator.
    Clin Cardiol. 2020 Sep 29. doi: 10.1002/clc.23471.
    PubMed     Abstract available

  65. ZILE MR, Desai AS, Agarwal R, Bharmi R, et al
    Prognostic value of brain natriuretic peptide vs history of heart failure hospitalization in a large real-world population.
    Clin Cardiol. 2020 Sep 19. doi: 10.1002/clc.23468.
    PubMed     Abstract available

    June 2020
  66. STEIN G, Teng TK, Tay WT, Richards AM, et al
    Ethnic differences in quality of life and its association with survival in patients with heart failure.
    Clin Cardiol. 2020 Jun 20. doi: 10.1002/clc.23394.
    PubMed     Abstract available

    May 2020
  67. ZAMANI SK, Samuel TJ, Wei J, Thomson LEJ, et al
    Left atrial stiffness in women with ischemia and no obstructive coronary artery disease: Novel insight from left atrial feature tracking.
    Clin Cardiol. 2020 May 27. doi: 10.1002/clc.23395.
    PubMed     Abstract available

  68. RAKISHEVA A, Marketou M, Klimenko A, Troyanova-Shchutskaia T, et al
    Hyperkalemia in heart failure: Foe or friend?
    Clin Cardiol. 2020 May 23. doi: 10.1002/clc.23392.
    PubMed     Abstract available

  69. JENTZER JC, Wiley B, Bennett C, Murphree DH, et al
    Early noncardiovascular organ failure and mortality in the cardiac intensive care unit.
    Clin Cardiol. 2020;43:516-523.
    PubMed     Abstract available

    April 2020
  70. SANTINI L, D'Onofrio A, Dello Russo A, Calo L, et al
    Prospective evaluation of the multisensor HeartLogic algorithm for heart failure monitoring.
    Clin Cardiol. 2020 Apr 18. doi: 10.1002/clc.23366.
    PubMed     Abstract available

  71. BRANKOVIC M, Akkerhuis KM, Hoorn EJ, van Boven N, et al
    Renal tubular damage and worsening renal function in chronic heart failure: Clinical determinants and relation to prognosis (Bio-SHiFT study).
    Clin Cardiol. 2020 Apr 16. doi: 10.1002/clc.23359.
    PubMed     Abstract available

  72. POPOVIC D, Arena R, Jakovljevic D, Ristic A, et al
    Ventricular arrhythmias not meeting criteria for terminating cardiopulmonary exercise testing stratify prognosis and disease severity in heart failure of preserved, midrange, and reduced ejection fraction.
    Clin Cardiol. 2020 Apr 9. doi: 10.1002/clc.23367.
    PubMed     Abstract available

    March 2020
  73. ZHANG Y, Li SY, Xie JJ, Wu Y, et al
    Twist/untwist parameters are promising evaluators of myocardial mechanic changes in heart failure patients with preserved ejection fraction.
    Clin Cardiol. 2020 Mar 25. doi: 10.1002/clc.23353.
    PubMed     Abstract available

  74. MARINI M, Branzoli S, Moggio P, Martin M, et al
    Epicardial left ventricular lead implantation in cardiac resynchronization therapy patients via a video-assisted thoracoscopic technique: Long-term outcome.
    Clin Cardiol. 2020;43:284-290.
    PubMed     Abstract available

    February 2020
  75. PALAU P, Seller J, Dominguez E, Gomez I, et al
    Beta-blockers withdrawal in patients with heart failure with preserved ejection fraction and chronotropic incompetence: Effect on functional capacity rationale and study design of a prospective, randomized, controlled trial (The Preserve-HR trial).
    Clin Cardiol. 2020 Feb 19. doi: 10.1002/clc.23345.
    PubMed     Abstract available

    January 2020
  76. HUANG Y, Wang Y, Huang Y, Zhai M, et al
    Prognostic value of sleep apnea and nocturnal hypoxemia in patients with decompensated heart failure.
    Clin Cardiol. 2020 Jan 22. doi: 10.1002/clc.23319.
    PubMed     Abstract available

    December 2019
  77. UPADHYA B, Kitzman DW
    Heart failure with preserved ejection fraction: New approaches to diagnosis and management.
    Clin Cardiol. 2019 Dec 26. doi: 10.1002/clc.23321.
    PubMed     Abstract available

  78. HESS PL, Matlock DD, Al-Khatib SM
    Decision-making regarding primary prevention implantable cardioverter-defibrillators among older adults.
    Clin Cardiol. 2019 Dec 23. doi: 10.1002/clc.23315.
    PubMed     Abstract available

  79. WILLIAMS BA, Geba D, Cordova JM, Shetty SS, et al
    A risk prediction model for heart failure hospitalization in type 2 diabetes mellitus.
    Clin Cardiol. 2019 Dec 14. doi: 10.1002/clc.23298.
    PubMed     Abstract available

  80. DRIGGIN E, Maurer MS
    The quintessential form of diastolic heart failure in older adults: Wild type transthyretin cardiac amyloidosis.
    Clin Cardiol. 2019 Dec 11. doi: 10.1002/clc.23301.
    PubMed     Abstract available

  81. METKUS TS, Stephens RS, Schulman S, Hsu S, et al
    Respiratory support in acute heart failure with preserved vs reduced ejection fraction.
    Clin Cardiol. 2019 Dec 11. doi: 10.1002/clc.23317.
    PubMed     Abstract available

    November 2019
  82. BLOOD AJ, Fischer CM, Fera LE, MacLean TE, et al
    Rationale and design of a navigator-driven remote optimization of guideline-directed medical therapy in patients with heart failure with reduced ejection fraction.
    Clin Cardiol. 2019 Nov 14. doi: 10.1002/clc.23291.
    PubMed     Abstract available

  83. CUNNINGHAM JW, Sun JL, Mc Causland FR, Ly S, et al
    Lower urine sodium predicts longer length of stay in acute heart failure patients: Insights from the ROSE AHF trial.
    Clin Cardiol. 2019 Nov 12. doi: 10.1002/clc.23286.
    PubMed     Abstract available

    October 2019
  84. JANG SY, Kang KW, Kim JH, Kim B, et al
    New-onset atrial fibrillation predicting for complicating cardiac adverse outcome in scrub typhus infection.
    Clin Cardiol. 2019 Oct 3. doi: 10.1002/clc.23276.
    PubMed     Abstract available

  85. BERTAGLIA E, Arena G, Pecora D, Reggiani A, et al
    The VALID-CRT risk score reliably predicts response and outcome of cardiac resynchronization therapy in a real-world population.
    Clin Cardiol. 2019;42:919-924.
    PubMed     Abstract available

    July 2019
  86. SCHUKRO C, Schloglhofer T, Khazen C, Rohrich M, et al
    Influence of a fully magnetically levitated left ventricular assist device on functional interrogation of implantable cardioverter defibrillators.
    Clin Cardiol. 2019 Jul 7. doi: 10.1002/clc.23228.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.